Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.

Abstract:

BACKGROUND:Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder, which is usually caused by de novo mutations in the MECP2 gene. More than 70% of the disease causing MECP2 mutations are eight recurrent C to T transitions, which almost exclusively arise on the paternally derived X chromosome. About 10% of the RTT cases have a C-terminal frameshift deletion in MECP2. Only few RTT families with a segregating MECP2 mutation, which affects female carriers with a phenotype of mental retardation or RTT, have been reported in the literature. In this study we describe two new RTT families with three and four individuals, respectively, and review the literature comparing the type of mutations and phenotypes observed in RTT families with those observed in sporadic cases. Based on these observations we also investigated origin of mutation segregation to further improve genetic counselling. METHODS:MECP2 mutations were identified by direct sequencing. XCI studies were performed using the X-linked androgen receptor (AR) locus. The parental origin of de novo MECP2 frameshift mutations was investigated using intronic SNPs. RESULTS:In both families a C-terminal frameshift mutation segregates. Clinical features of the mutation carriers vary from classical RTT to mild mental retardation. XCI profiles of the female carriers correlate to their respective geno-/phenotypes. The majority of the de novo frameshift mutations occur on the paternally derived X chromosome (7/9 cases), without a paternal age effect. CONCLUSIONS:The present study suggests a correlation between the intrafamilial phenotypic differences observed in RTT families and their respective XCI pattern in blood, in contrast to sporadic RTT cases where a similar correlation has not been demonstrated. Furthermore, we found de novo MECP2 frameshift mutations frequently to be of paternal origin, although not with the same high paternal occurrence as in sporadic cases with C to T transitions. This suggests further investigations of more families. This study emphasizes the need for thorough genetic counselling of families with a newly diagnosed RTT patient.

journal_name

Orphanet J Rare Dis

authors

Ravn K,Roende G,Duno M,Fuglsang K,Eiklid KL,Tümer Z,Nielsen JB,Skjeldal OH

doi

10.1186/1750-1172-6-58

subject

Has Abstract

pub_date

2011-08-30 00:00:00

pages

58

issn

1750-1172

pii

1750-1172-6-58

journal_volume

6

pub_type

杂志文章,评审
  • The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.

    abstract::In 1963, five cases of alpha1-antitrypsin deficiency were reported in the scientific literature, as well as an attempt to treat pulmonary alveolar proteinosis by a massive washing of the lung (whole lung lavage). Now, fifty years later, it seems the ideal moment not only to commemorate these publications, but also to ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-8-153

    authors: Trapnell BC,Luisetti M

    更新日期:2013-09-30 00:00:00

  • Pigmentary mosaicism: a review of original literature and recommendations for future handling.

    abstract:BACKGROUND:Pigmentary mosaicism is a term that describes varied patterns of pigmentation in the skin caused by genetic heterogeneity of the skin cells. In a substantial number of cases, pigmentary mosaicism is observed alongside extracutaneous abnormalities typically involving the central nervous system and the musculo...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-018-0778-6

    authors: Kromann AB,Ousager LB,Ali IKM,Aydemir N,Bygum A

    更新日期:2018-03-05 00:00:00

  • Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.

    abstract:BACKGROUND:The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS:A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierra...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01433-5

    authors: Gómez-Acebo I,Prado SR,De La Mora Á,Puente RZ,de la Roza Varela B,Dierssen-Sotos T,Llorca J

    更新日期:2020-06-29 00:00:00

  • Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis.

    abstract:BACKGROUND:Rapamycin has gained significant attention for its potential activity in reducing the size of TSC-associated tumors, thus providing alternative to surgery. This study aimed at determining the efficacy of rapamycin and rapalogs for reducing the size of TSC-associated solid tumors in patients with Tuberous Scl...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/s13023-015-0317-7

    authors: Sasongko TH,Ismail NF,Nik Abdul Malik NM,Zabidi-Hussin ZA

    更新日期:2015-08-12 00:00:00

  • The expanding spectrum of rare monogenic autoinflammatory diseases.

    abstract::Monogenic autoinflammatory diseases are a group of hereditary disorders characterized by a clinical and biological inflammatory syndrome in which there is little or no evidence of autoimmunity. The discovery of the first causative gene in 1997 was rapidly followed by the identification of many others from the same gro...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-8-162

    authors: Touitou I,Galeotti C,Rossi-Semerano L,Hentgen V,Piram M,Koné-Paut I,CeRéMAI, French reference center for autoinflammatory diseases.

    更新日期:2013-10-16 00:00:00

  • Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

    abstract:BACKGROUND:The clinical course of Cystic Fibrosis (CF) is usually measured using the percent predicted FEV(1) and BMI Z-score referenced against a healthy population, since achieving normality is the ultimate goal of CF care. Referencing against age and sex matched CF peers may provide valuable information for patients...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-7-64

    authors: Boëlle PY,Viviani L,Busson PF,Olesen HV,Ravilly S,Stern M,Assael BM,Barreto C,Drevinek P,Thomas M,Krivec U,Mei-Zahav M,Vibert JF,Clement A,Mehta A,Corvol H,French CF Modifier Gene Study Investigators.,European CF Regist

    更新日期:2012-09-07 00:00:00

  • Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.

    abstract:PURPOSE:Several gene therapy trials for Duchenne muscular dystrophy initiated in 2018. Trial decision making is complicated by non-curative, time-limited benefits; the progressive, fatal course; and high unmet needs. Here, caregivers and patients prioritize factors influencing decision making regarding participation in...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1069-6

    authors: Paquin RS,Fischer R,Mansfield C,Mange B,Beaverson K,Ganot A,Martin AS,Morris C,Rensch C,Ricotti V,Russo LJ,Sadosky A,Smith EC,Peay HL

    更新日期:2019-05-09 00:00:00

  • Quantitative assessment of left ventricular longitudinal function and myocardial deformation in Duchenne muscular dystrophy patients.

    abstract:BACKGROUND:Duchenne muscular dystrophy (DMD) manifests in males mainly by skeletal muscle impairment, but also by cardiac dysfunction. The assessment of the early phases of cardiac involvement using echocardiography is often very difficult to perform in these patients. The aim of the study was to use cardiac magnetic r...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-021-01704-9

    authors: Panovský R,Pešl M,Máchal J,Holeček T,Feitová V,Juříková L,Masárová L,Pešlová E,Opatřil L,Mojica-Pisciotti ML,Kincl V

    更新日期:2021-01-30 00:00:00

  • Impact of biobanks on research outcomes in rare diseases: a systematic review.

    abstract:BACKGROUND:Alleviating the burden of rare diseases requires research into new diagnostic and therapeutic strategies. We undertook a systematic review to identify and compare the impact of stand-alone registries, registries with biobanks, and rare disease biobanks on research outcomes in rare diseases. METHODS:A system...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-018-0942-z

    authors: Garcia M,Downs J,Russell A,Wang W

    更新日期:2018-11-12 00:00:00

  • MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients.

    abstract:BACKGROUND:Myosin heavy chain 7 (MYH7)-related myopathies are emerging as an important group of muscle diseases of childhood and adulthood, with variable clinical and histopathological expression depending on the type and location of the mutation. Mutations in the head and neck domains are a well-established cause of h...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0476-1

    authors: Fiorillo C,Astrea G,Savarese M,Cassandrini D,Brisca G,Trucco F,Pedemonte M,Trovato R,Ruggiero L,Vercelli L,D'Amico A,Tasca G,Pane M,Fanin M,Bello L,Broda P,Musumeci O,Rodolico C,Messina S,Vita GL,Sframeli M,Gibe

    更新日期:2016-07-07 00:00:00

  • Hamartomatous polyposis syndromes: a review.

    abstract::Hamartomatous Polyposis Syndromes (HPS) are genetic syndromes, which include Peutz-Jeghers syndrome, Juvenile polyposis syndrome, PTEN hamartoma tumour syndrome (Cowden Syndrom, Bannayan-Riley-Ruvalcaba and Proteus Syndrome) as well as hereditary mixed polyposis syndrome. Other syndromes such as Gorlin Syndrome and mu...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-9-101

    authors: Jelsig AM,Qvist N,Brusgaard K,Nielsen CB,Hansen TP,Ousager LB

    更新日期:2014-07-15 00:00:00

  • Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.

    abstract:BACKGROUND:A decision tree model was built to estimate the economic impact of introducing screening for X-linked adrenoleukodystrophy (X-ALD) into an existing tandem mass spectrometry based newborn screening programme. The model was based upon the UK National Health Service (NHS) Newborn Blood Spot Screening Programme ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-018-0921-4

    authors: Bessey A,Chilcott JB,Leaviss J,Sutton A

    更新日期:2018-10-11 00:00:00

  • The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks.

    abstract:BACKGROUND:Rare diseases (RDs) are often neglected because they affect a small percentage of the population (6-8 %), which makes research and development of new therapies challenging processes. Easy access to high-quality samples and associated clinical data is therefore a key prerequisite for biomedical research. In t...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0527-7

    authors: Baldo C,Casareto L,Renieri A,Merla G,Garavaglia B,Goldwurm S,Pegoraro E,Moggio M,Mora M,Politano L,Sangiorgi L,Mazzotti R,Viotti V,Meloni I,Pellico MT,Barzaghi C,Wang CM,Monaco L,Filocamo M

    更新日期:2016-10-24 00:00:00

  • Congenital cataract, facial dysmorphism and demyelinating neuropathy (CCFDN) in 10 Czech Gypsy children--frequent and underestimated cause of disability among Czech Gypsies.

    abstract:BACKGROUND:Congenital Cataract Facial Dysmorphism and demyelinating Neuropathy (CCFDN, OMIM 604468) is an autosomal recessive multi-system disorder which was first described in Bulgarian Gypsies in 1999. It is caused by the homozygous founder mutation c.863 + 389C > T in the CTDP1 gene. The syndrome has been described ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-9-46

    authors: Lassuthova P,Sišková D,Haberlová J,Sakmaryová I,Filouš A,Seeman P

    更新日期:2014-04-01 00:00:00

  • Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).

    abstract:BACKGROUND:LCHADD is a long-fatty acid oxidation disorder with immediate symptoms and long-term complications. We evaluated data on clinical status, biochemical parameters, therapeutic regimens and outcome of Austrian LCHADD patients. STUDY DESIGN:Clinical and outcome data including history, diagnosis, short- and long...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-015-0236-7

    authors: Karall D,Brunner-Krainz M,Kogelnig K,Konstantopoulou V,Maier EM,Möslinger D,Plecko B,Sperl W,Volkmar B,Scholl-Bürgi S

    更新日期:2015-02-22 00:00:00

  • miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.

    abstract:BACKGROUND:Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder, which is linked to the contraction of the D4Z4 array at chromosome 4q35. Recent studies suggest that this shortening of the D4Z4 array leads to aberrant expression of double homeobox protein 4 (DUX4) and causes FSHD. In a...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-55

    authors: Harafuji N,Schneiderat P,Walter MC,Chen YW

    更新日期:2013-04-05 00:00:00

  • Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy.

    abstract:BACKGROUND:Triglyceride deposit cardiomyovasculopathy (TGCV) is a rare disease, characterized by the massive accumulation of triglyceride (TG) in multiple tissues, especially skeletal muscle, heart muscle and the coronary artery. TGCV is caused by mutation of adipose triglyceride lipase, which is an essential molecule ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-197

    authors: Hara Y,Kawasaki N,Hirano K,Hashimoto Y,Adachi J,Watanabe S,Tomonaga T

    更新日期:2013-12-21 00:00:00

  • Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.

    abstract:BACKGROUND:Infants presenting with lysosomal acid lipase deficiency have marked failure to thrive, diarrhea, massive hepatosplenomegaly, anemia, rapidly progressive liver disease, and death typically in the first 6 months of life; the only available potential treatment has been hematopoietic stem cell transplantation, ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/s13023-017-0587-3

    authors: Jones SA,Rojas-Caro S,Quinn AG,Friedman M,Marulkar S,Ezgu F,Zaki O,Gargus JJ,Hughes J,Plantaz D,Vara R,Eckert S,Arnoux JB,Brassier A,Le Quan Sang KH,Valayannopoulos V

    更新日期:2017-02-08 00:00:00

  • Pain drawings as a diagnostic tool for the differentiation between two pain-associated rare diseases (Ehlers-Danlos-Syndrome, Guillain-Barré-Syndrome).

    abstract:BACKGROUND:The diagnosis of rare diseases poses a particular challenge to clinicians. This study analyzes whether patients' pain drawings (PDs) help in the differentiation of two pain-associated rare diseases, Ehlers-Danlos Syndrome (EDS) and Guillain-Barré Syndrome (GBS). METHOD:The study was designed as a prospectiv...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01542-1

    authors: Wester L,Mücke M,Bender TTA,Sellin J,Klawonn F,Conrad R,Szczypien N

    更新日期:2020-11-17 00:00:00

  • Patient reported outcome measures in rare diseases: a narrative review.

    abstract:BACKGROUND:Rare diseases can lead to a significant reduction in quality of life for patients and their families. Ensuring the patients voice is central to clinical decision making is key to delivering, evaluating and understanding the efficacy of therapeutic interventions. Patient reported outcome measures (PROMs) are ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-018-0810-x

    authors: Slade A,Isa F,Kyte D,Pankhurst T,Kerecuk L,Ferguson J,Lipkin G,Calvert M

    更新日期:2018-04-23 00:00:00

  • Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.

    abstract::Long-term complications and associated conditions of type 1 Gaucher Disease (GD) can include splenectomy, bone complications, pulmonary hypertension, Parkinson disease and malignancies. Enzyme replacement therapy (ERT) reverses cytopenia and reduces organomegaly. To study the effects of ERT on long-term complications ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-014-0112-x

    authors: van Dussen L,Biegstraaten M,Dijkgraaf MG,Hollak CE

    更新日期:2014-07-24 00:00:00

  • Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

    abstract::Cerebrotendinous xanthomatosis (CTX) OMIM#213700 is a rare autosomal-recessive lipid storage disease caused by mutations in the CYP27A1 gene; this gene codes for the mitochondrial enzyme sterol 27-hydroxylase, which is involved in bile acid synthesis. The CYP27A1 gene is located on chromosome 2q33-qter and contains ni...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-014-0179-4

    authors: Nie S,Chen G,Cao X,Zhang Y

    更新日期:2014-11-26 00:00:00

  • A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.

    abstract:BACKGROUND:Rare diseases are individually rare but globally affect around 6% of the population, and in over 70% of cases are genetically determined. Their rarity translates into a delayed diagnosis, with 25% of patients waiting 5 to 30 years for one. It is essential to raise awareness of patients and clinicians of exis...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01493-7

    authors: Atalaia A,Thompson R,Corvo A,Carmody L,Piscia D,Matalonga L,Macaya A,Lochmuller A,Fontaine B,Zurek B,Hernandez-Ferrer C,Rheinard C,Gómez-Andrés D,Desaphy JF,Schon K,Lohmann K,Jennings MJ,Synofzik M,Riess O,Yaou RB,

    更新日期:2020-08-12 00:00:00

  • Craniocervical junction malformation in a child with Oromandibular-limb hypogenesis-Möbius syndrome.

    abstract::We report a male child with Oromandibular-limb hypogenesis (OMLH), the main features being bilateral sixth and seventh nerve palsies, limb anomalies and hypoplasia of the tongue. Additional features were shortness of the neck associated with torticollis. Radiographs of the cervical spine were non-contributory, but 3D ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-2-2

    authors: Al Kaissi A,Grill F,Safi H,Ben Ghachem M,Ben Chehida F,Klaushofer K

    更新日期:2007-01-08 00:00:00

  • Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.

    abstract:BACKGROUND:Chronic obstructive pulmonary disease (COPD) is influenced by environmental and genetic factors. An important fraction of COPD cases harbor a major genetic determinant, inherited ZZ (Glu342Lys) α1-antitrypsin deficiency (AATD). A study was undertaken to investigate gene expression patterns in end-stage COPD ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-7-29

    authors: Koczulla AR,Jonigk D,Wolf T,Herr C,Noeske S,Klepetko W,Vogelmeier C,von Neuhoff N,Rische J,Wrenger S,Golpon H,Voswinckel R,Luisetti M,Ferrarotti I,Welte T,Janciauskiene S

    更新日期:2012-05-23 00:00:00

  • Incidence of inherited metabolic disorders in southern Israel: a comparison between consanguinity and non-consanguinity communities.

    abstract:BACKGROUND:Inherited metabolic disorders (IMDs) are group of rare monogenic diseases, usually derived from reduced or absent activity in a single metabolic pathway. Most of the IMDs are inherited in an autosomal recessive manner. The incidence of IMDs varies from country to country and within different ethnic groups, b...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01578-3

    authors: Hazan G,Hershkovitz E,Staretz-Chacham O

    更新日期:2020-11-25 00:00:00

  • Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism.

    abstract::Brazil is a country of continental dimensions, with many social inequalities. The latter are reflected on its health system, which comprises a large public component called SUS, a small paid health insurance component and a third very small private component, in which patients pay personally for medical services. Seve...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0458-3

    authors: Giugliani R,Vairo FP,Riegel M,de Souza CF,Schwartz IV,Pena SD

    更新日期:2016-06-10 00:00:00

  • Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.

    abstract:BACKGROUND:Glutaric aciduria type I (GA-I) is a rare metabolic disorder caused by inherited deficiency of glutaryl-CoA dehydrogenase. Despite high prognostic relevance of early diagnosis and start of metabolic treatment as well as an additional cost saving potential later in life, only a limited number of countries rec...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-167

    authors: Pfeil J,Listl S,Hoffmann GF,Kölker S,Lindner M,Burgard P

    更新日期:2013-10-17 00:00:00

  • Treatment management during the adolescent transition period of girls and young women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS): a systematic literature review.

    abstract:INTRODUCTION:In health services research, there is a special emphasis on the transition from adolescence into adulthood. During this transition period, adolescents change from pediatric to adult medical care. This process must be carefully structured, particularly when special medical care is required. Challenges and d...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0536-6

    authors: Wagner A,Brucker SY,Ueding E,Gröber-Grätz D,Simoes E,Rall K,Kronenthaler A,Schäffeler N,Rieger MA

    更新日期:2016-11-16 00:00:00

  • Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations.

    abstract:BACKGROUND:The needs and benefits of sharing health data to advance scientific research and improve clinical benefits have been well documented in recent years, specifically in the field of rare diseases where knowledge and expertise are limited and patient populations are geographically dispersed. Understanding what p...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1123-4

    authors: Courbier S,Dimond R,Bros-Facer V

    更新日期:2019-07-12 00:00:00